Mandatory notification of trade

03. Mar 2025 | 1 min read

Moss, 3 March 2025

Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction has been completed by a close associate of a primary insider in Gentian:

Holta Invest AS, a close associate of Espen Tidemann Jørgensen, a board member and primary insider in Gentian, has sold 1,228,502 shares in Gentian at NOK 46.50 per share.

PCA notification pursuant to the EU Market Abuse Regulation Article 19 is attached. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article 19 and Euronext Oslo Rule Book II.

For further information, please contact: Njaal Kind, Group CFO, njaal.kind@gentian.no, +47 91 90 65 25

 

Attachments are available on newsweb.

You may also read


Mar 20, 2026 - Ole Sørlie

Gentian Diagnostics: Annual report 2025

Moss, 20 March 2026 Gentian Diagnostics has today published its annual report for 2025. The annual report and..

Mar 12, 2026 - Ole Sørlie

Gentian Diagnostics ASA – Employee Share Purchase Program and share capital increase

Moss, 12 March 2026 Gentian Diagnostics ASA (the "Company") has completed the offer of new shares to..